Regulatory Mechanism of PD-L1 Expression in Primary Liver Cancer
The application of immunotherapy has become a hot spot in tumor research currently. In particular, immune checkpoint inhibitors have played an important role in the treatment of advanced unresectable primary liver cancer. However, the efficacy of immune checkpoint inhibitors varies greatly in the tr...
Guardado en:
Autores principales: | LI Shenghao, SHI Xinli |
---|---|
Formato: | article |
Lenguaje: | ZH |
Publicado: |
Magazine House of Cancer Research on Prevention and Treatment
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/aeb6ca2b49204a9f9fbb56777e5f963a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Various Uses of PD1/PD-L1 Inhibitor in Oncology: Opportunities and Challenges
por: Zhitao Li, et al.
Publicado: (2021) -
Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver
por: Xiangdong Ye, et al.
Publicado: (2021) -
Visual Analysis and Focused Areas of Immunotherapy for Liver Cancer Based on Literature Data
por: YANG Xi, et al.
Publicado: (2021) -
Research Progress on the Role of Regulatory T Cell in Tumor Microenvironment in the Treatment of Breast Cancer
por: Jianyu Liu, et al.
Publicado: (2021) -
Dl-3-N-Butylphthalide Presents Anti-Cancer Activity in Lung Cancer by Targeting PD-1/PD-L1 Signaling
por: Jiang Q, et al.
Publicado: (2021)